Olyth
Home
About
Terms
Privacy
Acumen Pharmaceuticals, Inc. (ABOS) Stock Price, Chart & News | Olyth
ABOS
Acumen Pharmaceuticals, Inc.
$2.63
-$0.07 (-2.59%)
Today
+$0.00 (+0.00%)
After Hours
1d
5d
1mo
6mo
1y
5y
max
Key Statistics
Market cap
189.96M
Price-Earnings ratio
-1.75
Dividend yield
—
Average volume
924.49K
High today
$2.72
Low today
$2.54
Open price
$2.72
Volume
318.17K
52 Week high
$3.60
52 Week low
$1.19
Company Profile
Recent News
Company Profile
No profile description available.
Recent News
ACCESS Newswire
7/9/2026
Acumen Pharmaceuticals and Unlearn Collaborate to Explore Analyses of Alzheimer's Disease Clinical Programs
GlobeNewswire
7/7/2026
Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026
MT Newswires
6/17/2026
Acumen Pharmaceuticals Exercises Option on Alzheimer's Program Using JCR's Technology
MT Newswires
6/16/2026
Acumen Pharmaceuticals Nominates 2 Drug Candidates to Treat Alzheimer's Disease
Exec Edge
6/16/2026
Acumen Nominates 2 Therapies to Treat Alzheimer’s Disease
Business Wire
6/17/2026
JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform
GlobeNewswire
6/16/2026
Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease
GuruFocus.com
5/12/2026
Acumen Pharmaceuticals Inc (ABOS) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...